Immunomedics
TRODELVY
Manufacturer:
Immunomedics
Name:
TRODELVY
HCPCS Code Descriptor:
Injection, sacituzumab govitecan-hziy, 2.5 mg
Category:
J Code
HCPCS:
J9317
NDC(s):
55135-0132-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
TRODELVY is an Oncology drug manufactured by Immunomedics and administered via the Intravenous route of administration. The J Code: J9317 is aligned to the drug TRODELVY.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/21
HCPCS Effective Date:
1/1/21
HCPCS Short Description:
Sacituzumab govitecan-hziy
Billing and Coding Guide:
https://www.trodelvyhcp.com/-/media/project/trodelvy/trodelvyhcp/hcp/resource-pdf/reimbursement-billing-coding-guide-2021-trot00107.pdf
Patient Assistance:
https://www.trodelvy.com/